1. Academic Validation
  2. Targeting KRAS G12D Mutant for the Potential Treatment of Pancreatic Cancer

Targeting KRAS G12D Mutant for the Potential Treatment of Pancreatic Cancer

  • ACS Med Chem Lett. 2021 Oct 19;12(11):1643-1645. doi: 10.1021/acsmedchemlett.1c00545.
Robert B Kargbo 1
Affiliations

Affiliation

  • 1 Usona Institute, 277 Granada Drive, San Luis Obispo, California 93401-7337, United States.
Figures
Products